Maternal/neonatal vitamin D deficiency: a new risk factor for necrotizing enterocolitis in preterm infants?

M Cetinkaya1, T Erener-Ercan2, T Kalayci-Oral1

  • 1Department of Neonatology, Kanuni Sultan Suleyman Teaching and Research Hospital, Istanbul, Turkey.

Insights

Maternal and neonatal vitamin D deficiency may increase the risk of necrotizing enterocolitis (NEC) in preterm infants. Lower vitamin D levels were observed in infants who developed NEC, highlighting a potential link.

Area of Science:

  • Neonatal Medicine
  • Nutritional Science
  • Pediatric Gastroenterology

Background:

  • Necrotizing enterocolitis (NEC) is a serious gastrointestinal condition affecting preterm infants.
  • Vitamin D plays a crucial role in immune function and gut health.
  • Low vitamin D levels are common in preterm infants and their mothers.

Purpose of the Study:

  • To investigate the association between maternal and neonatal 25-hydroxy vitamin D (25-OHD) levels and the development of NEC.
  • To determine if vitamin D status is a predictive factor for NEC in preterm neonates.

Main Methods:

  • Prospective study involving 145 preterm infants (gestation ≤36 weeks).
  • Maternal and neonatal blood samples collected upon admission to the neonatal intensive care unit.
  • Measurement of 25-hydroxy vitamin D (25-OHD) levels.

Main Results:

  • 26% of enrolled infants developed NEC.
  • Significantly lower maternal and neonatal 25-OHD levels were found in the NEC group compared to the no-NEC group.
  • Univariate analysis showed both maternal and neonatal 25-OHD levels as significant predictors of NEC. Multivariate analysis identified maternal 25-OHD levels as the sole significant predictor.

Conclusions:

  • This study suggests a potential association between maternal vitamin D status and the risk of NEC in preterm infants.
  • Maternal vitamin D deficiency may be a risk factor for NEC development.
  • Further research is warranted to confirm these findings and explore potential interventions.
Abstract

Related Concept Videos

Vitamins01:30

Vitamins

Vitamins, derived from the Latin word for life, are essential organic substances required in small quantities for optimal growth and overall well-being. Unlike other organic nutrients, vitamins don't act as sources of energy or building materials but rather facilitate these nutrients' utilization by the body. Vitamins are predominantly coenzymes, assisting enzymes in specific chemical actions, like the oxidation of glucose for energy involving B vitamins. Most vitamins are not produced...
2.7K
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
4.0K
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
65
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
503
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
555